102 - Alternative Strategies to Monitor CMV Reactivation After Transplantation

10/4/2019

8:00 AM - 9:00 AM

Room: Walter E. Washington Convention Center, 150 AB

MOC Credit: Maximum of 1.0 hours of MOC Credit
CME Credit: Maximum of 1.0 hours of AMA PRA Category 1 Credit™
ACPE Credit: ACPE 1 knowledge-based contact hours of pharmacy CE
ACPE Number: 0221-9999-19-355-L01-P

Learning Objectives:

At the conclusion of this session, participants will be able to:

discuss the potential role of quantification of torque teno virus as an innovative predictive biomarker for risk of infection in transplant recipients and other immunocompromised individuals
discuss the ability of CMV T-cell response assays to predict CMV reactivation and its outcome in transplant recipients and other immunocompromised individuals

Presentations:

8:00 AM - 9:00 AM
906 - Cytomegalovirus T-Cell Response Assays
Roy F. Chemaly, MD, MPH, FACP, FIDSA – The University of Texas MD Anderson Cancer Center
8:00 AM - 9:00 AM
905 - Torque Tenovirus Viral Load as a Novel Biomarker of the Net State of Immunosuppression after Transplant
Camille Kotton, MD – Massachusetts General Hospital

Speaker(s)

Roy Chemaly, MD, MPH, FACP, FIDSA

Professor
The University of Texas MD Anderson Cancer Center
Houston, TX

Disclosure: Chimerix: Advisory Board, Research Grant
Clinigen: Advisory Board
Merck: Advisory Board, Consultant, Grant/Research Support, Research Grant, Speaker's Bureau
Oxford immunotec: Consultant, Grant/Research Support
Shire: Research Grant, Speaker's Bureau
Viracor: Grant/Research Support
Camille Kotton, MD

clinical director, transplant ID
Massachusetts General Hospital
Boston, MA

Disclosure: Nothing to disclose